Literature DB >> 1531241

Lipoprotein(a). Clinical approach to a unique atherogenic lipoprotein.

D J Rader, H B Brewer.   

Abstract

Mesh:

Substances:

Year:  1992        PMID: 1531241     DOI: 10.1001/jama.267.8.1109

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  The Apo(a) gene is the major determinant of variation in plasma Lp(a) levels in African Americans.

Authors:  V Mooser; D Scheer; S M Marcovina; J Wang; R Guerra; J Cohen; H H Hobbs
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

Review 2.  [Drug treatment strategies for peripheral obliterative arteriopathy].

Authors:  H Bounameaux; R Wütschert
Journal:  Drugs       Date:  1998       Impact factor: 9.546

3.  Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular events.

Authors:  Jacqueline Suk Danik; Nader Rifai; Julie E Buring; Paul M Ridker
Journal:  J Am Coll Cardiol       Date:  2008-07-08       Impact factor: 24.094

4.  Gemfibrozil treatment in patients with elevated lipoprotein a: a pilot study.

Authors:  A G Fereshetian; M Davidson; H Haber; D M Black
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

5.  Effects of renal replacement therapy on plasma lipoprotein(a) levels.

Authors:  Sylvia Rosas; Marshall Joffe; Megan Wolfe; Kenneth Brayman; Daniel J Rader
Journal:  Am J Nephrol       Date:  2007-12-05       Impact factor: 3.754

6.  The Lipid Parameters and Lipoprotein(a) Excess in Hashimoto Thyroiditis.

Authors:  D O Yetkin; B Dogantekin
Journal:  Int J Endocrinol       Date:  2015-05-03       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.